High Incidence of Veno‐Occlusive Disease With Myeloablative Chemotherapy Following Craniospinal Irradiation in Children With Newly Diagnosed High‐Risk CNS Embryonal Tumors: A Report From the Children's Oncology Group (CCG‐99702)
Kellie J. Nazemi(Oregon Health & Science University), H. Stacy Nicholson(University of Arizona), Deborah A. Lafond(Children's Hospital of Orange County), Roger J. Packer(Children's Hospital of Philadelphia), Sharon L. Gardner(NYU Langone Health), Jonathan L. Finlay(The Ohio State University), James M. Boyett(University of Illinois Chicago), Violet Shen(Ruhr University Bochum), Mehmet Koçak(St. Jude Children's Research Hospital)
Cited by 22
Related Papers
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
|Acta Neuropathologica|2016|650
Long-Term Outcomes Among Adult Survivors of Childhood Central Nervous System Malignancies in the Childhood Cancer Survivor Study
|JNCI Journal of the National Cancer Institute|2009|530
Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy
|Journal of neurosurgery|1994|508
Conventional Compared with Individualized Chemotherapy for Childhood Acute Lymphoblastic Leukemia
|New England Journal of Medicine|1998|501